{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:51:07Z","timestamp":1792741867867,"version":"4.5.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Immunol"],"published-print":{"date-parts":[[2003,10,1]]},"DOI":"10.1038\/nri1201","type":"journal-article","created":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T18:52:27Z","timestamp":1065034347000},"page":"801-812","source":"Crossref","is-referenced-by-count":431,"title":["B cells under influence: transformation of B cells by Epstein\u2013Barr virus"],"prefix":"10.1038","volume":"3","author":[{"given":"Ralf","family":"K\u00fcppers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnri1201_CR1","first-page":"2575","volume-title":"Fields Virology","author":"AB Rickinson","year":"2001","unstructured":"Rickinson, A. B. & Kieff, E. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2575\u20132627 (Lippincott\u2013Raven, Philadelphia, 2001)."},{"key":"BFnri1201_CR2","first-page":"477","volume":"3","author":"HB Jenson","year":"1996","unstructured":"Jenson, H. B. Acute Epstein\u2013Barr virus infections. Bailliere's Clin. Infect. Dis. 3, 477\u2013506 (1996).","journal-title":"Bailliere's Clin. Infect. Dis."},{"key":"BFnri1201_CR3","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/emboj\/17.6.1700","volume":"17","author":"E Kilger","year":"1998","unstructured":"Kilger, E., Kieser, A., Baumann, M. & Hammerschmidt, W. Epstein\u2013Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J. 17, 1700\u20131709 (1998).","journal-title":"EMBO J."},{"key":"BFnri1201_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S1074-7613(00)80623-8","volume":"9","author":"RG Caldwell","year":"1998","unstructured":"Caldwell, R. G., Wilson, J. B., Anderson, S. J. & Longnecker, R. Epstein\u2013Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9, 405\u2013411 (1998). This study shows that expression of latent membrane protein 2A (LMP2A) allows immunoglobulin-negative B cells to survive and colonize peripheral lymphoid organs, indicating that LMP2A can replace the survival signal normally supplied by the B-cell receptor (BCR).","journal-title":"Immunity"},{"key":"BFnri1201_CR5","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1006\/scbi.2001.0414","volume":"11","author":"P Smith","year":"2001","unstructured":"Smith, P. Epstein\u2013Barr virus complementary strand transcripts (CSTs\/BARTs) and cancer. Semin. Cancer Biol. 11, 468\u2013476 (2001).","journal-title":"Semin. Cancer Biol."},{"key":"BFnri1201_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S1074-7613(00)80493-8","volume":"5","author":"G Khan","year":"1996","unstructured":"Khan, G., Miyashita, E. M., Yang, B., Babcock, G. J. & Thorley-Lawson, D. A. Is EBV persistence in vivo a model for B cell homeostasis? Immunity 5, 173\u2013179 (1996).","journal-title":"Immunity"},{"key":"BFnri1201_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S1074-7613(00)00049-2","volume":"13","author":"GJ Babcock","year":"2000","unstructured":"Babcock, G. J., Hochberg, D. & Thorley-Lawson, D. A. The expression pattern of Epstein\u2013Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 13, 497\u2013506 (2000). This paper shows that the expression pattern of Epstein\u2013Barr virus (EBV)-encoded genes depends on the differentiation stage of the infected B cells. These findings are the basis for a model of viral strategies during persistent infection.","journal-title":"Immunity"},{"key":"BFnri1201_CR8","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/S0024-3205(99)00214-3","volume":"65","author":"DA Thorley-Lawson","year":"1999","unstructured":"Thorley-Lawson, D. A. & Babcock, G. J. A model for persistent infection with Epstein\u2013Barr virus: the stealth virus of human B cells. Life Sci. 65, 1433\u20131453 (1999).","journal-title":"Life Sci."},{"key":"BFnri1201_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/35095584","volume":"1","author":"DA Thorley-Lawson","year":"2001","unstructured":"Thorley-Lawson, D. A. Epstein\u2013Barr virus: exploiting the immune system. Nature Rev. Immunol. 1, 75\u201382 (2001).","journal-title":"Nature Rev. Immunol."},{"key":"BFnri1201_CR10","doi-asserted-by":"publisher","first-page":"9964","DOI":"10.1128\/JVI.74.21.9964-9971.2000","volume":"74","author":"AM Joseph","year":"2000","unstructured":"Joseph, A. M., Babcock, G. J. & Thorley-Lawson, D. A. Cells expressing the Epstein\u2013Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils. J. Virol. 74, 9964\u20139971 (2000).","journal-title":"J. Virol."},{"key":"BFnri1201_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S1074-7613(00)80622-6","volume":"9","author":"GJ Babcock","year":"1998","unstructured":"Babcock, G. J., Decker, L. L., Volk, M. & Thorley-Lawson, D. A. EBV persistence in memory B cells in vivo. Immunity 9, 395\u2013404 (1998).","journal-title":"Immunity"},{"key":"BFnri1201_CR12","doi-asserted-by":"publisher","first-page":"D346","DOI":"10.2741\/Rowe","volume":"4","author":"DT Rowe","year":"1999","unstructured":"Rowe, D. T. Epstein\u2013Barr virus immortalization and latency. Front. Biosci. 4, D346\u2013D371 (1999).","journal-title":"Front. Biosci."},{"key":"BFnri1201_CR13","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/intimm\/5.7.707","volume":"5","author":"RK Cheung","year":"1993","unstructured":"Cheung, R. K., Miyazaki, I. & Dosch, H. M. Unexpected patterns of Epstein\u2013Barr virus gene expression during early stages of B cell transformation. Int. Immunol. 5, 707\u2013716 (1993).","journal-title":"Int. Immunol."},{"key":"BFnri1201_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1046\/j.1365-2567.2003.01601.x","volume":"108","author":"B Ehlin-Henriksson","year":"2003","unstructured":"Ehlin-Henriksson, B., Gordon, J. & Klein, G. B-lymphocyte subpopulations are equally susceptible to Epstein\u2013Barr virus infection, irrespective of immunoglobulin isotype expression. Immunol. 108, 427\u2013430 (2003).","journal-title":"Immunol."},{"key":"BFnri1201_CR15","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S1074-7613(02)00318-7","volume":"16","author":"LL Laichalk","year":"2002","unstructured":"Laichalk, L. L., Hochberg, D., Babcock, G. J., Freeman, R. B. & Thorley-Lawson, D. A. The dispersal of mucosal memory B cells: evidence from persistent EBV infection. Immunity 16, 745\u2013754 (2002).","journal-title":"Immunity"},{"key":"BFnri1201_CR16","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/(SICI)1096-9896(199902)187:3<326::AID-PATH242>3.0.CO;2-N","volume":"187","author":"I Araujo","year":"1999","unstructured":"Araujo, I. et al. Frequent expansion of Epstein\u2013Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma. J. Pathol. 187, 326\u2013330 (1999).","journal-title":"J. Pathol."},{"key":"BFnri1201_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/mp.54.4.264","volume":"54","author":"N Meru","year":"2001","unstructured":"Meru, N. et al. Epstein\u2013Barr virus infection in paediatric liver transplant recipients: detection of the virus in post-transplant tonsillectomy specimens. Mol. Pathol. 54, 265\u2013269 (2001).","journal-title":"Mol. Pathol."},{"key":"BFnri1201_CR18","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1182\/blood.V79.10.2520.bloodjournal79102520","volume":"79","author":"G Niedobitek","year":"1992","unstructured":"Niedobitek, G. et al. Patterns of Epstein\u2013Barr virus infection in non-neoplastic lymphoid tissue. Blood 79, 2520\u20132526 (1992).","journal-title":"Blood"},{"key":"BFnri1201_CR19","unstructured":"Capello, D. et al. Molecular histogenesis of posttransplant lymphoproliferative disorders. Blood (in the press)."},{"key":"BFnri1201_CR20","first-page":"155","volume":"150","author":"A Carbone","year":"1997","unstructured":"Carbone, A. et al. BCL-6 protein expression in AIDS-related non-Hodgkin's lymphomas: inverse relationship with Epstein\u2013Barr virus-encoded latent membrane protein-1 expression. Am. J. Pathol. 150, 155\u2013165 (1997).","journal-title":"Am. J. Pathol."},{"key":"BFnri1201_CR21","first-page":"175a","volume":"90","author":"G Cattoretti","year":"1997","unstructured":"Cattoretti, G. et al. Downregulation of BCL-6 gene expression by CD40 and EBV latent membrane protein-1 (LMP-1) and its block in lymphoma carrying BCL-6 rearrangements. Blood 90, 175a (1997).","journal-title":"Blood"},{"key":"BFnri1201_CR22","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1126\/science.286.5438.300","volume":"286","author":"J Uchida","year":"1999","unstructured":"Uchida, J. et al. Mimicry of CD40 signals by Epstein\u2013Barr virus LMP1 in B lymphocyte responses. Science 286, 300\u2013303 (1999). Evidence is provided that constitutive expression of LMP1 by mouse B cells on the one hand mimics CD40 signalling, but on the other hand also blocks B cells from differentiating into germinal-centre B cells.","journal-title":"Science"},{"key":"BFnri1201_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/ijc.2910170105","volume":"17","author":"G Klein","year":"1976","unstructured":"Klein, G., Svedmyr, E., Jondal, M. & Persson, P. O. EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients. Int. J. Cancer 17, 21\u201326 (1976).","journal-title":"Int. J. Cancer"},{"key":"BFnri1201_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1146\/annurev.immunol.15.1.405","volume":"15","author":"AB Rickinson","year":"1997","unstructured":"Rickinson, A. B. & Moss, D. J. Human cytotoxic T lymphocyte responses to Epstein\u2013Barr virus infection. Annu. Rev. Immunol. 15, 405\u2013431 (1997).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnri1201_CR25","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S1074-7613(00)00048-0","volume":"13","author":"J Kurth","year":"2000","unstructured":"Kurth, J. et al. EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency. Immunity 13, 485\u2013495 (2000). This molecular analysis of EBV-infected B cells in infectious mononucleosis indicated the viral strategies during acute primary infection.","journal-title":"Immunity"},{"key":"BFnri1201_CR26","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.1073\/pnas.2627966100","volume":"100","author":"J Kurth","year":"2003","unstructured":"Kurth, J., Hansmann, M. -L., Rajewsky, K. & K\u00fcppers, R. Epstein\u2013Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction. Proc. Natl Acad. Sci. USA 100, 4730\u20134735 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1201_CR27","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1136\/jcp.50.11.911","volume":"50","author":"AA Brink","year":"1997","unstructured":"Brink, A. A. et al. Presence of Epstein\u2013Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas. J. Clin. Pathol. 50, 911\u2013918 (1997).","journal-title":"J. Clin. Pathol."},{"key":"BFnri1201_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/(SICI)1096-9896(199706)182:2<151::AID-PATH824>3.0.CO;2-3","volume":"182","author":"G Niedobitek","year":"1997","unstructured":"Niedobitek, G. et al. Epstein\u2013Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells. J. Pathol. 182, 151\u2013159 (1997).","journal-title":"J. Pathol."},{"key":"BFnri1201_CR29","first-page":"4273","volume":"52","author":"KG Bhatia","year":"1992","unstructured":"Bhatia, K. G., Gutierrez, M. I., Huppi, K., Siwarski, D. & Magrath, I. T. The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors. Cancer Res. 52, 4273\u20134276 (1992).","journal-title":"Cancer Res."},{"key":"BFnri1201_CR30","doi-asserted-by":"publisher","first-page":"5413","DOI":"10.1073\/pnas.88.12.5413","volume":"88","author":"G Gaidano","year":"1991","unstructured":"Gaidano, G. et al. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 88, 5413\u20135417 (1991).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1201_CR31","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0002-9440(10)64941-3","volume":"156","author":"C Cinti","year":"2000","unstructured":"Cinti, C. et al. Genetic alterations of the retinoblastoma-related gene RB2\/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes. Am. J. Pathol. 156, 751\u2013760 (2000).","journal-title":"Am. J. Pathol."},{"key":"BFnri1201_CR32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4049\/jimmunol.139.1.313","volume":"139","author":"CD Gregory","year":"1987","unstructured":"Gregory, C. D. et al. Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype. J. Immunol. 139, 313\u2013318 (1987).","journal-title":"J. Immunol."},{"key":"BFnri1201_CR33","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/ijc.2910430122","volume":"43","author":"NR Ling","year":"1989","unstructured":"Ling, N. R. et al. A phenotypic study of cells from Burkitt lymphoma and EBV-B-lymphoblastoid lines and their relationship to cells in normal lymphoid tissues. Int. J. Cancer 43, 112\u2013118 (1989).","journal-title":"Int. J. Cancer"},{"key":"BFnri1201_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1182\/blood.V86.1.28.bloodjournal86128","volume":"86","author":"T Onizuka","year":"1995","unstructured":"Onizuka, T. et al. BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. Blood 86, 28\u201337 (1995).","journal-title":"Blood"},{"key":"BFnri1201_CR35","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1182\/blood.V85.8.2176.bloodjournal8582176","volume":"85","author":"CJ Chapman","year":"1995","unstructured":"Chapman, C. J., Mockridge, C. I., Rowe, M., Rickinson, A. B. & Stevenson, F. K. Analysis of VH genes used by neoplastic B cells in endemic Burkitt's lymphoma shows somatic hypermutation and intraclonal heterogeneity. Blood 85, 2176\u20132181 (1995).","journal-title":"Blood"},{"key":"BFnri1201_CR36","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1182\/blood.V88.9.3562.bloodjournal8893562","volume":"88","author":"CJ Chapman","year":"1996","unstructured":"Chapman, C. J., Zhou, J. X., Gregory, C., Rickinson, A. B. & Stevenson, F. K. VH and VL gene analysis in sporadic Burkitt's lymphoma shows somatic hypermutation, intraclonal heterogeneity, and a role for antigen selection. Blood 88, 3562\u20133568 (1996).","journal-title":"Blood"},{"key":"BFnri1201_CR37","doi-asserted-by":"publisher","first-page":"10488","DOI":"10.1128\/JVI.75.21.10488-10492.2001","volume":"75","author":"RS Harris","year":"2001","unstructured":"Harris, R. S., Croom-Carter, D. S., Rickinson, A. B. & Neuberger, M. S. Epstein\u2013Barr virus and the somatic hypermutation of immunoglobulin genes in Burkitt's lymphoma cells. J. Virol. 75, 10488\u201310492 (2001).","journal-title":"J. Virol."},{"key":"BFnri1201_CR38","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S1074-7613(00)80651-2","volume":"9","author":"JE Sale","year":"1998","unstructured":"Sale, J. E. & Neuberger, M. S. TdT-accessible breaks are scattered over the immunoglobulin V domain in a constitutively hypermutating B cell line. Immunity 9, 859\u2013869 (1998).","journal-title":"Immunity"},{"key":"BFnri1201_CR39","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1073\/pnas.95.5.2463","volume":"95","author":"T Goossens","year":"1998","unstructured":"Goossens, T., Klein, U. & K\u00fcppers, R. Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease. Proc. Natl Acad. Sci. USA 95, 2463\u20132468 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1201_CR40","doi-asserted-by":"publisher","first-page":"5580","DOI":"10.1038\/sj.onc.1204640","volume":"20","author":"R K\u00fcppers","year":"2001","unstructured":"K\u00fcppers, R. & Dalla-Favera, R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20, 5580\u20135594 (2001).","journal-title":"Oncogene"},{"key":"BFnri1201_CR41","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1098\/rstb.2000.0781","volume":"356","author":"GW Bornkamm","year":"2001","unstructured":"Bornkamm, G. W. & Hammerschmidt, W. Molecular virology of Epstein\u2013Barr virus. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356, 437\u2013459 (2001).","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"BFnri1201_CR42","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1002\/j.1460-2075.1996.tb00674.x","volume":"15","author":"JB Wilson","year":"1996","unstructured":"Wilson, J. B., Bell, J. L. & Levine, A. J. Expression of Epstein\u2013Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J. 15, 3117\u20133126 (1996).","journal-title":"EMBO J."},{"key":"BFnri1201_CR43","doi-asserted-by":"publisher","first-page":"6742","DOI":"10.1093\/emboj\/19.24.6742","volume":"19","author":"N Kitagawa","year":"2000","unstructured":"Kitagawa, N. et al. Epstein\u2013Barr virus-encoded poly(A)\u2212 RNA supports Burkitt's lymphoma growth through interleukin-10 induction. EMBO J. 19, 6742\u20136750 (2000).","journal-title":"EMBO J."},{"key":"BFnri1201_CR44","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/emboj\/21.5.954","volume":"21","author":"A Nanbo","year":"2002","unstructured":"Nanbo, A., Inoue, K., Adachi-Takasawa, K. & Takada, K. Epstein\u2013Barr virus RNA confers resistance to interferon-\u03b1-induced apoptosis in Burkitt's lymphoma. EMBO J. 21, 954\u2013965 (2002).","journal-title":"EMBO J."},{"key":"BFnri1201_CR45","first-page":"HY1","volume":"9","author":"HH Niller","year":"2003","unstructured":"Niller, H. H. et al. The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein\u2013Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis. Med. Sci. Monit. 9, HY1\u20139 (2003).","journal-title":"Med. Sci. Monit."},{"key":"BFnri1201_CR46","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1073\/pnas.0730710100","volume":"100","author":"C Kiss","year":"2003","unstructured":"Kiss, C. et al. T cell leukemia I oncogene expression depends on the presence of Epstein\u2013Barr virus in the virus-carrying Burkitt lymphoma lines. Proc. Natl Acad. Sci. USA 100, 4813\u20134818 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1201_CR47","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/nm758","volume":"8","author":"G Kelly","year":"2002","unstructured":"Kelly, G., Bell, A. & Rickinson, A. Epstein\u2013Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. Nature Med. 8, 1098\u20131104 (2002).","journal-title":"Nature Med."},{"key":"BFnri1201_CR48","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/ijc.1404","volume":"93","author":"A Pajic","year":"2001","unstructured":"Pajic, A. et al. Antagonistic effects of c-myc and Epstein\u2013Barr virus latent genes on the phenotype of human B cells. Int. J. Cancer 93, 810\u2013816 (2001).","journal-title":"Int. J. Cancer"},{"key":"BFnri1201_CR49","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/j.1460-2075.1996.tb00367.x","volume":"15","author":"N Jochner","year":"1996","unstructured":"Jochner, N. et al. Epstein\u2013Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin \u03bc gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells. EMBO J. 15, 375\u2013382 (1996).","journal-title":"EMBO J."},{"key":"BFnri1201_CR50","first-page":"101","volume-title":"Hodgkin's disease","author":"LM Weiss","year":"1999","unstructured":"Weiss, L. M., Chan, J. K. C., MacLennan, K. & Warnke, R. A. in Hodgkin's disease (eds Mauch, P. M., Armitage, J. O., Diehl, V., Hoppe, R. T. & Weiss, L. M.) 101\u2013120 (Lippincott Williams & Wilkins, Philadelphia, 1999)."},{"key":"BFnri1201_CR51","first-page":"220","volume":"36","author":"NL Harris","year":"1999","unstructured":"Harris, N. L. Hodgkin's lymphomas: classification, diagnosis, and grading. Semin. Hematol. 36, 220\u2013232 (1999).","journal-title":"Semin. Hematol."},{"key":"BFnri1201_CR52","first-page":"260","volume":"36","author":"RF Jarrett","year":"1999","unstructured":"Jarrett, R. F. & MacKenzie, J. Epstein\u2013Barr virus and other candidate viruses in the pathogenesis of Hodgkin's disease. Semin. Hematol. 36, 260\u2013269 (1999).","journal-title":"Semin. Hematol."},{"key":"BFnri1201_CR53","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1084\/jem.184.4.1495","volume":"184","author":"H Kanzler","year":"1996","unstructured":"Kanzler, H., K\u00fcppers, R., Hansmann, M. L. & Rajewsky, K. Hodgkin and Reed\u2013Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J. Exp. Med. 184, 1495\u20131505 (1996).","journal-title":"J. Exp. Med."},{"key":"BFnri1201_CR54","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0065-230X(02)84009-X","volume":"84","author":"R K\u00fcppers","year":"2002","unstructured":"K\u00fcppers, R. Molecular biology of Hodgkin's lymphoma. Adv. Cancer Res. 84, 277\u2013312 (2002).","journal-title":"Adv. Cancer Res."},{"key":"BFnri1201_CR55","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1182\/blood.V95.4.1443.004k55_1443_1450","volume":"95","author":"T Marafioti","year":"2000","unstructured":"Marafioti, T. et al. Hodgkin and Reed\u2013Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 95, 1443\u20131450 (2000).","journal-title":"Blood"},{"key":"BFnri1201_CR56","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/342929a0","volume":"342","author":"YJ Liu","year":"1989","unstructured":"Liu, Y. J. et al. Mechanism of antigen-driven selection in germinal centres. Nature 342, 929\u2013931 (1989).","journal-title":"Nature"},{"key":"BFnri1201_CR57","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.1073\/pnas.88.11.4766","volume":"88","author":"H Herbst","year":"1991","unstructured":"Herbst, H. et al. Epstein\u2013Barr virus latent membrane protein expression in Hodgkin and Reed\u2013Sternberg cells. Proc. Natl Acad. Sci. USA 88, 4766\u20134770 (1991).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1201_CR58","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1182\/blood.V90.4.1664","volume":"90","author":"G Niedobitek","year":"1997","unstructured":"Niedobitek, G. et al. Immunohistochemical detection of the Epstein\u2013Barr virus-encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis. Blood 90, 1664\u20131672 (1997).","journal-title":"Blood"},{"key":"BFnri1201_CR59","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/0140-6736(91)90943-J","volume":"337","author":"G Pallesen","year":"1991","unstructured":"Pallesen, G., Hamilton-Dutoit, S. J., Rowe, M. & Young, L. S. Expression of Epstein\u2013Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337, 320\u2013322 (1991).","journal-title":"Lancet"},{"key":"BFnri1201_CR60","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1182\/blood-2002-03-0839","volume":"101","author":"I Schwering","year":"2003","unstructured":"Schwering, I. et al. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed\u2013Sternberg cells of Hodgkin lymphoma. Blood 101, 1505\u20131512 (2003).","journal-title":"Blood"},{"key":"BFnri1201_CR61","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1084\/jem.194.3.255","volume":"194","author":"N Engels","year":"2001","unstructured":"Engels, N. et al. Epstein\u2013Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module. J. Exp. Med. 194, 255\u2013264 (2001).","journal-title":"J. Exp. Med."},{"key":"BFnri1201_CR62","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/BF00838049","volume":"20","author":"DM Knowles","year":"1998","unstructured":"Knowles, D. M. The molecular genetics of post-transplantation lymphoproliferative disorders. Springer Sem. Immunopathol. 20, 357\u2013373 (1998).","journal-title":"Springer Sem. Immunopathol."},{"key":"BFnri1201_CR63","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/eji.200323765","volume":"33","author":"A Br\u00e4uninger","year":"2003","unstructured":"Br\u00e4uninger, A. et al. Epstein\u2013Barr virus (EBV)-positive lymphoproliferations in posttransplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes. Eur. J. Immunol. 33, 1593\u20131602 (2003).","journal-title":"Eur. J. Immunol."},{"key":"BFnri1201_CR64","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0140-6736(03)12271-4","volume":"361","author":"JM Timms","year":"2003","unstructured":"Timms, J. M. et al. Target cells of Epstein\u2013Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma. Lancet 361, 217\u2013223 (2003). References 63 and 64 (as well as reference 19) show that post-transplant lymphomas derive from the transformation of diverse types of B cell, including selected and 'crippled' germinal-centre B cells.","journal-title":"Lancet"},{"key":"BFnri1201_CR65","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1056\/NEJM199911113412007","volume":"341","author":"R K\u00fcppers","year":"1999","unstructured":"K\u00fcppers, R., Klein, U., Hansmann, M. -L. & Rajewsky, K. Cellular origin of human B-cell lymphomas. N. Engl. J. Med. 341, 1520\u20131529 (1999).","journal-title":"N. Engl. J. Med."},{"key":"BFnri1201_CR66","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0145-2126(00)00060-6","volume":"24","author":"GS Arbus","year":"2000","unstructured":"Arbus, G. S. et al. Verotoxin targets lymphoma infiltrates of patients with post-transplant lymphoproliferative disease. Leuk. Res. 24, 857\u2013864 (2000).","journal-title":"Leuk. Res."},{"key":"BFnri1201_CR67","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/BF02634361","volume":"30A","author":"PS Randhawa","year":"1994","unstructured":"Randhawa, P. S. et al. Morphologic and immunophenotypic characterization of a cell line derived from liver tissue with Epstein\u2013Barr virus associated post-transplant lymphoproliferative disease. In Vitro Cell. Dev. Biol. Anim. 30A, 400\u2013406 (1994).","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"BFnri1201_CR68","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s11626-997-0160-9","volume":"33","author":"P Randhawa","year":"1997","unstructured":"Randhawa, P. et al. In vitro culture of B-lymphocytes derived from Epstein\u2013Barr-virus-associated posttransplant lymphoproliferative disease: cytokine production and effect of interferon-\u03b1. In Vitro Cell. Dev. Biol. Anim. 33, 803\u2013808 (1997).","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"BFnri1201_CR69","first-page":"877","volume":"10","author":"JM Armitage","year":"1991","unstructured":"Armitage, J. M. et al. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J. Heart Lung Transplant. 10, 877\u2013886 (1991).","journal-title":"J. Heart Lung Transplant."},{"key":"BFnri1201_CR70","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1136\/jcp.53.4.248","volume":"53","author":"P Hopwood","year":"2000","unstructured":"Hopwood, P. & Crawford, D. H. The role of EBV in post-transplant malignancies: a review. J. Clin. Pathol. 53, 248\u2013254 (2000).","journal-title":"J. Clin. Pathol."},{"key":"BFnri1201_CR71","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1182\/blood.V80.7.1804.1804","volume":"80","author":"I Anagnostopoulos","year":"1992","unstructured":"Anagnostopoulos, I. et al. Heterogeneous Epstein\u2013Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 80, 1804\u20131812 (1992).","journal-title":"Blood"},{"key":"BFnri1201_CR72","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1182\/blood.V79.7.1789.1789","volume":"79","author":"LM Weiss","year":"1992","unstructured":"Weiss, L. M. et al. Detection and localization of Epstein\u2013Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood 79, 1789\u20131795 (1992).","journal-title":"Blood"},{"key":"BFnri1201_CR73","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1084\/jem.194.7.927","volume":"194","author":"A Br\u00e4uninger","year":"2001","unstructured":"Br\u00e4uninger, A. et al. Survival and clonal expansion of mutating 'forbidden' (immunoglobulin receptor-deficient) Epstein\u2013Barr virus-infected B cells in angioimmunoblastic T cell lymphoma. J. Exp. Med. 194, 927\u2013940 (2001).","journal-title":"J. Exp. Med."},{"key":"BFnri1201_CR74","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/S0092-8674(00)80373-6","volume":"90","author":"KP Lam","year":"1997","unstructured":"Lam, K. P., K\u00fchn, R. & Rajewsky, K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90, 1073\u20131083 (1997).","journal-title":"Cell"},{"key":"BFnri1201_CR75","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/infdis\/173.3.529","volume":"173","author":"BI Razzouk","year":"1996","unstructured":"Razzouk, B. I., Srinivas, S., Sample, C. E., Singh, V. & Sixbey, J. W. Epstein\u2013Barr Virus DNA recombination and loss in sporadic Burkitt's lymphoma. J. Infect. Dis. 173, 529\u2013535 (1996).","journal-title":"J. Infect. Dis."},{"key":"BFnri1201_CR76","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S0002-9440(10)64900-0","volume":"160","author":"YJ Gan","year":"2002","unstructured":"Gan, Y. J., Razzouk, B. I., Su, T. & Sixbey, J. W. A defective, rearranged Epstein\u2013Barr virus genome in EBER-negative and EBER-positive Hodgkin's disease. Am. J. Pathol. 160, 781\u2013786 (2002).","journal-title":"Am. J. Pathol."},{"key":"BFnri1201_CR77","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1038\/sj.onc.1202893","volume":"18","author":"E Cabannes","year":"1999","unstructured":"Cabannes, E., Khan, G., Aillet, F., Jarrett, R. F. & Hay, R. T. Mutations in the I\u03baB\u03b1 gene in Hodgkin's disease suggest a tumour suppressor role for I\u03baB\u03b1. Oncogene 18, 3063\u20133070 (1999).","journal-title":"Oncogene"},{"key":"BFnri1201_CR78","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1182\/blood.V94.9.3129","volume":"94","author":"F Emmerich","year":"1999","unstructured":"Emmerich, F. et al. Overexpression of I\u03baB\u03b1 without inhibition of NF-\u03baB activity and mutations in the I\u03baB\u03b1 gene in Reed\u2013Sternberg cells. Blood 94, 3129\u20133134 (1999).","journal-title":"Blood"},{"key":"BFnri1201_CR79","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1182\/blood.V99.4.1381","volume":"99","author":"S Joos","year":"2002","unstructured":"Joos, S. et al. Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. Blood 99, 1381\u20131387 (2002).","journal-title":"Blood"},{"key":"BFnri1201_CR80","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1084\/jem.191.2.395","volume":"191","author":"B Jungnickel","year":"2000","unstructured":"Jungnickel, B. et al. Clonal deleterious mutations in the I\u03baB\u03b1 gene in the malignant cells in Hodgkin's disease. J. Exp. Med. 191, 395\u2013401 (2000).","journal-title":"J. Exp. Med."},{"key":"BFnri1201_CR81","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1182\/blood.V99.4.1474","volume":"99","author":"JI Martin-Subero","year":"2002","unstructured":"Martin-Subero, J. I. et al. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. Blood 99, 1474\u20131477 (2002).","journal-title":"Blood"},{"key":"BFnri1201_CR82","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/1097-0215(20001201)88:5<744::AID-IJC10>3.0.CO;2-E","volume":"88","author":"F Fais","year":"2000","unstructured":"Fais, F. et al. Analysis of stepwise genetic changes in an AIDS-related Burkitt's lymphoma. Int. J. Cancer 88, 744\u2013750 (2000).","journal-title":"Int. J. Cancer"},{"key":"BFnri1201_CR83","unstructured":"Tinguely, M. et al. Molecular single cell analysis of a composite mantle cell and Hodgkin lymphoma shows a common origin and indicates Epstein\u2013Barr virus infection of a Hodgkin\/Reed\u2013Sternberg cell precursor in a germinal center reaction. Am. J. Surg. Pathol. (in the press)."},{"key":"BFnri1201_CR84","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/nri953","volume":"2","author":"AL Shaffer","year":"2002","unstructured":"Shaffer, A. L., Rosenwald, A. & Staudt, L. M. Lymphoid malignancies: the dark side of B-cell differentiation. Nature Rev. Immunol. 2, 920\u2013932 (2002).","journal-title":"Nature Rev. Immunol."},{"key":"BFnri1201_CR85","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0065-230X(01)83004-9","volume":"83","author":"FK Stevenson","year":"2001","unstructured":"Stevenson, F. K. et al. The occurrence and significance of V gene mutations in B cell-derived human malignancy. Adv. Cancer Res. 83, 81\u2013116 (2001).","journal-title":"Adv. Cancer Res."},{"key":"BFnri1201_CR86","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1146\/annurev.immunol.16.1.471","volume":"16","author":"R K\u00fcppers","year":"1998","unstructured":"K\u00fcppers, R. & Rajewsky, K. The origin of Hodgkin and Reed\u2013Sternberg cells in Hodgkin's disease. Annu. Rev. Immunol. 16, 471\u2013493 (1998).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnri1201_CR87","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/313812a0","volume":"313","author":"JL Yates","year":"1985","unstructured":"Yates, J. L., Warren, N. & Sugden, B. Stable replication of plasmids derived from Epstein\u2013Barr virus in various mammalian cells. Nature 313, 812\u2013815 (1985).","journal-title":"Nature"},{"key":"BFnri1201_CR88","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/375685a0","volume":"375","author":"J Levitskaya","year":"1995","unstructured":"Levitskaya, J. et al. Inhibition of antigen processing by the internal repeat region of the Epstein\u2013Barr virus nuclear antigen-1. Nature 375, 685\u2013688 (1995).","journal-title":"Nature"},{"key":"BFnri1201_CR89","first-page":"2343","volume-title":"Fields Virology","author":"E Kieff","year":"1996","unstructured":"Kieff, E. in Fields Virology (eds Fields, B. N., Knipe, D. M. & Howley, P. M.) 2343\u20132396 (Lippincott\u2013Raven, Philadelphia, 1996)."},{"key":"BFnri1201_CR90","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1006\/scbi.2001.0409","volume":"11","author":"U Zimber-Strobl","year":"2001","unstructured":"Zimber-Strobl, U. & Strobl, L. J. EBNA2 and Notch signalling in Epstein\u2013Barr virus mediated immortalization of B lymphocytes. Semin. Cancer Biol. 11, 423\u2013434 (2001).","journal-title":"Semin. Cancer Biol."},{"key":"BFnri1201_CR91","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/0092-8674(85)90256-9","volume":"43","author":"D Wang","year":"1985","unstructured":"Wang, D., Liebowitz, D. & Kieff, E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43, 831\u2013840 (1985).","journal-title":"Cell"},{"key":"BFnri1201_CR92","doi-asserted-by":"publisher","first-page":"11963","DOI":"10.1073\/pnas.95.20.11963","volume":"95","author":"W Kulwichit","year":"1998","unstructured":"Kulwichit, W. et al. Expression of the Epstein\u2013Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc. Natl Acad. Sci. USA 95, 11963\u201311968 (1998). This study shows that transgenic mice expressing LMP1 in B cells develop lymphomas, establishing LMP1 as an oncogene for B cells.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1201_CR93","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0092-8674(95)90489-1","volume":"80","author":"G Mosialos","year":"1995","unstructured":"Mosialos, G. et al. The Epstein\u2013Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80, 389\u2013399 (1995).","journal-title":"Cell"},{"key":"BFnri1201_CR94","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1084\/jem.193.8.943","volume":"193","author":"KD Brown","year":"2001","unstructured":"Brown, K. D., Hostager, B. S. & Bishop, G. A. Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein\u2013Barr virus oncoprotein latent membrane protein 1 (LMP1). J. Exp. Med. 193, 943\u2013954 (2001).","journal-title":"J. Exp. Med."},{"key":"BFnri1201_CR95","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0960-9822(93)90196-U","volume":"3","author":"G Alber","year":"1993","unstructured":"Alber, G. et al. Molecular mimicry of the antigen receptor signalling motif by transmembrane proteins of the Epstein\u2013Barr virus and the bovine leukemia virus. Curr. Biol. 3, 333\u2013339 (1993).","journal-title":"Curr. Biol."},{"key":"BFnri1201_CR96","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1074-7613(95)80040-9","volume":"2","author":"CL Miller","year":"1995","unstructured":"Miller, C. L. et al. Integral membrane protein 2 of Epstein\u2013Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 2, 155\u2013166 (1995).","journal-title":"Immunity"},{"key":"BFnri1201_CR97","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3109\/08830180109045591","volume":"20","author":"M Merchant","year":"2001","unstructured":"Merchant, M. et al. The effects of the Epstein\u2013Barr virus latent membrane protein 2A on B cell function. Int. Rev. Immunol. 20, 805\u2013835 (2001).","journal-title":"Int. Rev. Immunol."},{"key":"BFnri1201_CR98","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/381751a0","volume":"381","author":"K Rajewsky","year":"1996","unstructured":"Rajewsky, K. Clonal selection and learning in the antibody system. Nature 381, 751\u2013758 (1996).","journal-title":"Nature"},{"key":"BFnri1201_CR99","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev.iy.12.040194.001001","volume":"12","author":"IC MacLennan","year":"1994","unstructured":"MacLennan, I. C. Germinal centers. Annu. Rev. Immunol. 12, 117\u2013139 (1994).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnri1201_CR100","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1002\/j.1460-2075.1993.tb06189.x","volume":"12","author":"R K\u00fcppers","year":"1993","unstructured":"K\u00fcppers, R., Zhao, M., Hansmann, M. L. & Rajewsky, K. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J. 12, 4955\u20134967 (1993).","journal-title":"EMBO J."}],"container-title":["Nature Reviews Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nri1201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nri1201","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nri1201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T01:22:49Z","timestamp":1682558569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nri1201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,1]]},"references-count":100,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,10,1]]}},"alternative-id":["BFnri1201"],"URL":"https:\/\/doi.org\/10.1038\/nri1201","relation":{},"ISSN":["1474-1733","1474-1741"],"issn-type":[{"value":"1474-1733","type":"print"},{"value":"1474-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,1]]}}}